Company profile SRPT

Sarepta Therapeutics Inc
sarepta therapeutics is a biopharmaceutical company focused on the discovery and development of unique rna-targeted therapeutics for the treatment of rare, infectious and other diseases. the company is primarily focused on rapidly advancing the development of its potentially disease-modifying dmd drug candidates, including its lead dmd product candidate, eteplirsen, designed to... skip exon 51. sarepta is also developing therapeutics for the treatment of infectious diseases, such as drug-resistant bacteria and other rare human diseases. for more information, please visit us at www.sarepta.com. Show More
Quarter analysis & expected interestLast update: February 08 2024 02:03:07.

After 38 days of this quarter the interest is at 103.0. Based on that we can calculate that during remaining 53 days it will total up to 247.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019154
238
54.5% QoQ
304
27.7% QoQ
287
-5.6% QoQ
2020 235
52.6% YoY -18.1% QoQ
232
-2.5% YoY -1.3% QoQ
215
-29.3% YoY -7.3% QoQ
189
-34.1% YoY -12.1% QoQ
2021 435
85.1% YoY 130.2% QoQ
147
-36.6% YoY -66.2% QoQ
147
-31.6% YoY 0.0% QoQ
159
-15.9% YoY 8.2% QoQ
2022 224
-48.5% YoY 40.9% QoQ
183
24.5% YoY -18.3% QoQ
213
44.9% YoY 16.4% QoQ
204
28.3% YoY -4.2% QoQ
2023 320
42.9% YoY 56.9% QoQ
413
125.7% YoY 29.1% QoQ
247
16.0% YoY -40.2% QoQ
329
61.3% YoY 33.2% QoQ
2024 103
-67.8% YoY -68.7% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Sarepta Therapeutics search interestLast update: February 08 2024 02:03:07.
Correlation coefficient between keyword and revenue is 0.06
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 02:03:08.

The average 5 years interest of Sarepta Therapeutics was 19.07 per week.
The last year interest of Sarepta Therapeutics compared to the last 5 years has changed by 25.96%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 15.09%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 02:03:13.

After 38 days of this quarter the interest is at 76.0. Based on that we can calculate that during remaining 53 days it will total up to 182.0.
Sarepta Therapeutics news expected interest is significantly higher compared to previous quarter (+89.6%) and same quarter last year (+435.3%).

YearQ1Q2Q3Q4
2019172
157
-8.7% QoQ
247
57.3% QoQ
270
9.3% QoQ
2020 139
-19.2% YoY -48.5% QoQ
95
-39.5% YoY -31.7% QoQ
140
-43.3% YoY 47.4% QoQ
0
-100.0% YoY -100.0% QoQ
2021 223
60.4% YoY inf% QoQ
78
-17.9% YoY -65.0% QoQ
83
-40.7% YoY 6.4% QoQ
133
inf% YoY 60.2% QoQ
2022 85
-61.9% YoY -36.1% QoQ
57
-26.9% YoY -32.9% QoQ
39
-53.0% YoY -31.6% QoQ
0
-100.0% YoY -100.0% QoQ
2023 34
-60.0% YoY inf% QoQ
94
64.9% YoY 176.5% QoQ
88
125.6% YoY -6.4% QoQ
96
inf% YoY 9.1% QoQ
2024 76
123.5% YoY -20.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Sarepta Therapeutics news search interestLast update: February 08 2024 02:03:13.
Correlation coefficient between keyword and revenue is -0.63
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 02:03:13.

The average 5 years interest of Sarepta Therapeutics news was 8.84 per week.
The last year interest of Sarepta Therapeutics news compared to the last 5 years has changed by -18.67%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -57.61%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 02:03:17.

After 38 days of this quarter the interest is at 66.0. Based on that we can calculate that during remaining 53 days it will total up to 158.0.
Sarepta Therapeutics stock expected interest is significantly higher compared to same quarter last year (+56.4%) but lower than previous quarter (-45.3%).

YearQ1Q2Q3Q4
201959
122
106.8% QoQ
134
9.8% QoQ
140
4.5% QoQ
2020 84
42.4% YoY -40.0% QoQ
117
-4.1% YoY 39.3% QoQ
101
-24.6% YoY -13.7% QoQ
40
-71.4% YoY -60.4% QoQ
2021 326
288.1% YoY 715.0% QoQ
128
9.4% YoY -60.7% QoQ
74
-26.7% YoY -42.2% QoQ
80
100.0% YoY 8.1% QoQ
2022 89
-72.7% YoY 11.2% QoQ
53
-58.6% YoY -40.4% QoQ
58
-21.6% YoY 9.4% QoQ
129
61.2% YoY 122.4% QoQ
2023 101
13.5% YoY -21.7% QoQ
190
258.5% YoY 88.1% QoQ
165
184.5% YoY -13.2% QoQ
289
124.0% YoY 75.2% QoQ
2024 66
-34.7% YoY -77.2% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Sarepta Therapeutics stock search interestLast update: February 08 2024 02:03:17.
Correlation coefficient between keyword and revenue is -0.04
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 02:03:17.

The average 5 years interest of Sarepta Therapeutics stock was 9.75 per week.
The last year interest of Sarepta Therapeutics stock compared to the last 5 years has changed by 50.26%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 51.19%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Sarepta Therapeutics treatment to provide analysis

Correlation between past revenue and Sarepta Therapeutics treatment search interest

There is not enough data for Sarepta Therapeutics treatment to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Sarepta Therapeutics treatment to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Sarepta Therapeutics CEO to provide analysis

Correlation between past revenue and Sarepta Therapeutics CEO search interest

There is not enough data for Sarepta Therapeutics CEO to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Sarepta Therapeutics CEO to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 03:42:35.

After 39 days of this quarter the interest is at 348.0. Based on that we can calculate that during remaining 52 days it will total up to 812.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019539
711
31.9% QoQ
475
-33.2% QoQ
679
42.9% QoQ
2020 768
42.5% YoY 13.1% QoQ
588
-17.3% YoY -23.4% QoQ
477
0.4% YoY -18.9% QoQ
564
-16.9% YoY 18.2% QoQ
2021 851
10.8% YoY 50.9% QoQ
780
32.7% YoY -8.3% QoQ
675
41.5% YoY -13.5% QoQ
681
20.7% YoY 0.9% QoQ
2022 827
-2.8% YoY 21.4% QoQ
781
0.1% YoY -5.6% QoQ
551
-18.4% YoY -29.4% QoQ
720
5.7% YoY 30.7% QoQ
2023 897
8.5% YoY 24.6% QoQ
777
-0.5% YoY -13.4% QoQ
554
0.5% YoY -28.7% QoQ
825
14.6% YoY 48.9% QoQ
2024 348
-61.2% YoY -57.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and gene therapy search interestLast update: February 09 2024 03:42:34.
Correlation coefficient between keyword and revenue is 0.98
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 03:42:39.

The average 5 years interest of gene therapy was 53.9 per week.
The last year interest of gene therapy compared to the last 5 years has changed by 7.37%.
The interest for gene therapy is seasonal.
The last year interest is comparable to 5 years ago. It has changed only by 10.84%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for RNA-targeted therapeutics to provide analysis

Correlation between past revenue and RNA-targeted therapeutics search interest

There is not enough data for RNA-targeted therapeutics to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for RNA-targeted therapeutics to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 20:50:20.

After 39 days of this quarter the interest is at 353.0. Based on that we can calculate that during remaining 52 days it will total up to 824.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019677
744
9.9% QoQ
650
-12.6% QoQ
843
29.7% QoQ
2020 905
33.7% YoY 7.4% QoQ
671
-9.8% YoY -25.9% QoQ
601
-7.5% YoY -10.4% QoQ
608
-27.9% YoY 1.2% QoQ
2021 650
-28.2% YoY 6.9% QoQ
524
-21.9% YoY -19.4% QoQ
531
-11.6% YoY 1.3% QoQ
657
8.1% YoY 23.7% QoQ
2022 812
24.9% YoY 23.6% QoQ
778
48.5% YoY -4.2% QoQ
704
32.6% YoY -9.5% QoQ
847
28.9% YoY 20.3% QoQ
2023 937
15.4% YoY 10.6% QoQ
847
8.9% YoY -9.6% QoQ
698
-0.9% YoY -17.6% QoQ
925
9.2% YoY 32.5% QoQ
2024 353
-62.3% YoY -61.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Duchenne muscular dystrophy search interestLast update: February 08 2024 20:50:20.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 20:50:24.

The average 5 years interest of Duchenne muscular dystrophy was 57.33 per week.
The last year interest of Duchenne muscular dystrophy compared to the last 5 years has changed by 11.93%.
The interest for Duchenne muscular dystrophy is seasonal.
The last year interest is comparable to 5 years ago. It has changed only by 0.72%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for exon skipping therapy to provide analysis

Correlation between past revenue and exon skipping therapy search interest

There is not enough data for exon skipping therapy to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for exon skipping therapy to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 18:07:12.

After 39 days of this quarter the interest is at 248.0. Based on that we can calculate that during remaining 52 days it will total up to 579.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019563
733
30.2% QoQ
706
-3.7% QoQ
735
4.1% QoQ
2020 770
36.8% YoY 4.8% QoQ
537
-26.7% YoY -30.3% QoQ
507
-28.2% YoY -5.6% QoQ
524
-28.7% YoY 3.4% QoQ
2021 577
-25.1% YoY 10.1% QoQ
543
1.1% YoY -5.9% QoQ
489
-3.6% YoY -9.9% QoQ
535
2.1% YoY 9.4% QoQ
2022 722
25.1% YoY 35.0% QoQ
672
23.8% YoY -6.9% QoQ
600
22.7% YoY -10.7% QoQ
639
19.4% YoY 6.5% QoQ
2023 740
2.5% YoY 15.8% QoQ
658
-2.1% YoY -11.1% QoQ
565
-5.8% YoY -14.1% QoQ
656
2.7% YoY 16.1% QoQ
2024 248
-66.5% YoY -62.2% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and rare diseases search interestLast update: February 09 2024 18:07:11.
Correlation coefficient between keyword and revenue is 0.36
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 18:07:13.

The average 5 years interest of rare diseases was 48.73 per week.
The last year interest of rare diseases compared to the last 5 years has changed by 0.29%.
The interest for rare diseases is seasonal.
The last year interest is quite lower compared to 5 years ago. It has decreased by -16.79%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for SRPT
Earnings date: 2024-02-27 After close
Company name: Sarepta Therapeutics Inc
Sector: Manufacturing
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-13T20:30:00Z

BusinessWire
Sarepta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference

2026-05-13T17:37:47.109Z

Reuters
Makary exit may temporarily lift biotech sentiment but FDA leadership vacuum looms

2026-05-06T20:05:00Z

BusinessWire
Sarepta Therapeutics Announces First Quarter 2026 Financial Results and Recent Corporate Developments

2026-04-24T16:21:13-04:00

SEC
ARS Form - Annual Report to Security Holders - Sarepta Therapeutics, Inc. (0000873303) (Filer)

2026-04-24T16:11:01-04:00

SEC
DEFA14A Form - Additional definitive proxy soliciting materials and Rule 14(a)(12) material - Sarepta Therapeutics, Inc. (0000873303) (Filer)

2026-04-24T16:10:20-04:00

SEC
DEF 14A Form - Other definitive proxy statements - Sarepta Therapeutics, Inc. (0000873303) (Filer)

2026-04-22T12:30:00Z

BusinessWire
Sarepta Therapeutics to Announce First Quarter 2026 Financial Results

2026-04-20T12:30:00Z

GlobeNewswire
When Science Becomes an Asset: How Advancing Drug Pipelines Are Driving Real-Time Valuation in Biotech

2026-04-16T16:59:35Z

Analyst Upgrades
HC Wainwright & Co. Reiterates Sell on Sarepta Therapeutics, Maintains $5 Price Target

2026-03-31T20:05:00Z

BusinessWire
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

2026-03-26T15:25:50Z

Analyst Upgrades
Citigroup Maintains Sell on Sarepta Therapeutics, Raises Price Target to $13

2026-03-25T12:05:00Z

BusinessWire
Sarepta Announces First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1

2026-03-24T20:05:00Z

BusinessWire
Sarepta to Share First Clinical Data from siRNA Pipeline Targeting FSHD1 and DM1

2026-03-19T14:38:30Z

Analyst Upgrades
Oppenheimer Reiterates Outperform on Sarepta Therapeutics, Maintains $37 Price Target

2026-03-19T12:30:00Z

BusinessWire
Sarepta Provides Regulatory Update on AMONDYS 45® and VYONDYS 53®